Blincyto (blinatumomab) - Amgen
Effects of Immunoglobulin Repletion in Adults With B-Cell Acute Lymphoblastic Leukemia Receiving Blinatumomab (SOHO 2026) - Sep 1, 2026 - Abstract #ALL-1713; "B-ALL: B-cell acute lymphoblastic leukemia, IVIG: intravenous immunoglobulin, SPSS: Statistical Package for the Social Sciences. This abstract has been accepted for publication at the 2026 EHACongress." 
Clinical • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Lymphoma • Multiple Myeloma • Oncology
https://www.sciencedirect.com/science/article/abs/pii/S2152265026017271
 
Emma Matzinger BS 1; Nikesh Shah MD 2; David Swoboda MD 2; Daniel Kerr MD,PhD 2
 
Sep 1, 2026
 
Prev Next